PA-19-034 - Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R43/R44 Clinical Trial Not Allowed)
is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Active NOSIs
| Title |
Notice Number |
Organization |
Release
Date |
Expiration
Date |
Activity
Code(s) |
Expired NOSIs
| Title |
Notice Number |
Organization |
Release
Date |
Expiration
Date |
Activity
Code(s) |
| Notice of Special Interest for Small Business Research in Genomics |
NOT-GM-19-041 |
NIGMS
|
May 15, 2019 |
Sep 6, 2021
|
R43/R44 |
|
Warning! This browser is not supported - Some features might not work. Try using a different browser such as Chrome, Edge, Firefox, or Safari.
NIH Staff 
